nodes	percent_of_prediction	percent_of_DWPC	metapath
Tubocurarine—HTR3A—cranial nerve—amyotrophic lateral sclerosis	0.0617	0.187	CbGeAlD
Tubocurarine—CHRNA1—tongue—amyotrophic lateral sclerosis	0.0521	0.158	CbGeAlD
Tubocurarine—HTR3A—nerve—amyotrophic lateral sclerosis	0.0316	0.0961	CbGeAlD
Tubocurarine—HTR3A—brainstem—amyotrophic lateral sclerosis	0.0136	0.0412	CbGeAlD
Tubocurarine—CHRNB1—medulla oblongata—amyotrophic lateral sclerosis	0.0123	0.0374	CbGeAlD
Tubocurarine—CHRNB1—spinal cord—amyotrophic lateral sclerosis	0.011	0.0334	CbGeAlD
Tubocurarine—ACHE—medulla oblongata—amyotrophic lateral sclerosis	0.0107	0.0325	CbGeAlD
Tubocurarine—SLC22A1—Na+/Cl- dependent neurotransmitter transporters—SLC6A1—amyotrophic lateral sclerosis	0.0102	0.0152	CbGpPWpGaD
Tubocurarine—CHRNA2—nervous system—amyotrophic lateral sclerosis	0.00995	0.0302	CbGeAlD
Tubocurarine—CHRNA2—central nervous system—amyotrophic lateral sclerosis	0.00958	0.0291	CbGeAlD
Tubocurarine—ACHE—spinal cord—amyotrophic lateral sclerosis	0.00953	0.0289	CbGeAlD
Tubocurarine—CHRNA2—cerebellum—amyotrophic lateral sclerosis	0.00936	0.0285	CbGeAlD
Tubocurarine—HTR3A—Ion channel transport—TRPM7—amyotrophic lateral sclerosis	0.00934	0.0139	CbGpPWpGaD
Tubocurarine—CHRNA1—brain—amyotrophic lateral sclerosis	0.00917	0.0279	CbGeAlD
Tubocurarine—ACHE—Monoamine Transport—SLC6A1—amyotrophic lateral sclerosis	0.00906	0.0135	CbGpPWpGaD
Tubocurarine—CHRNB1—cerebellum—amyotrophic lateral sclerosis	0.00871	0.0265	CbGeAlD
Tubocurarine—CHRND—Neurotransmitter Receptor Binding And Downstream Transmission In The Postsynaptic Cell—KCNJ10—amyotrophic lateral sclerosis	0.00824	0.0123	CbGpPWpGaD
Tubocurarine—HTR3A—SIDS Susceptibility Pathways—ECE1—amyotrophic lateral sclerosis	0.00818	0.0122	CbGpPWpGaD
Tubocurarine—CHRND—Neurotransmitter Receptor Binding And Downstream Transmission In The Postsynaptic Cell—GRIA2—amyotrophic lateral sclerosis	0.00761	0.0113	CbGpPWpGaD
Tubocurarine—CHRNA2—brain—amyotrophic lateral sclerosis	0.00761	0.0231	CbGeAlD
Tubocurarine—SLC22A2—Amine compound SLC transporters—SLC6A1—amyotrophic lateral sclerosis	0.0076	0.0113	CbGpPWpGaD
Tubocurarine—ACHE—cerebellum—amyotrophic lateral sclerosis	0.00755	0.023	CbGeAlD
Tubocurarine—HTR3A—nervous system—amyotrophic lateral sclerosis	0.00711	0.0216	CbGeAlD
Tubocurarine—SLC22A1—Amine compound SLC transporters—SLC6A1—amyotrophic lateral sclerosis	0.00708	0.0106	CbGpPWpGaD
Tubocurarine—CHRNB1—brain—amyotrophic lateral sclerosis	0.00708	0.0215	CbGeAlD
Tubocurarine—CHRNA1—Neurotransmitter Receptor Binding And Downstream Transmission In The Postsynaptic Cell—KCNJ10—amyotrophic lateral sclerosis	0.00701	0.0104	CbGpPWpGaD
Tubocurarine—HTR3A—central nervous system—amyotrophic lateral sclerosis	0.00685	0.0208	CbGeAlD
Tubocurarine—CHRND—Neurotransmitter Receptor Binding And Downstream Transmission In The Postsynaptic Cell—NEFL—amyotrophic lateral sclerosis	0.00672	0.01	CbGpPWpGaD
Tubocurarine—CHRNA2—Neurotransmitter Receptor Binding And Downstream Transmission In The Postsynaptic Cell—KCNJ10—amyotrophic lateral sclerosis	0.00666	0.00992	CbGpPWpGaD
Tubocurarine—SLC22A2—Neurotransmitter Release Cycle—CHAT—amyotrophic lateral sclerosis	0.00652	0.00971	CbGpPWpGaD
Tubocurarine—CHRNA1—Neurotransmitter Receptor Binding And Downstream Transmission In The Postsynaptic Cell—GRIA2—amyotrophic lateral sclerosis	0.00647	0.00964	CbGpPWpGaD
Tubocurarine—ACHE—Phospholipid metabolism—SACM1L—amyotrophic lateral sclerosis	0.00646	0.00964	CbGpPWpGaD
Tubocurarine—CHRND—Transmission across Chemical Synapses—KCNJ10—amyotrophic lateral sclerosis	0.0062	0.00924	CbGpPWpGaD
Tubocurarine—CHRNA2—Neurotransmitter Receptor Binding And Downstream Transmission In The Postsynaptic Cell—GRIA2—amyotrophic lateral sclerosis	0.00614	0.00916	CbGpPWpGaD
Tubocurarine—ACHE—brain—amyotrophic lateral sclerosis	0.00614	0.0186	CbGeAlD
Tubocurarine—ACHE—Phospholipid metabolism—FIG4—amyotrophic lateral sclerosis	0.00608	0.00906	CbGpPWpGaD
Tubocurarine—SLC22A1—Neurotransmitter Release Cycle—CHAT—amyotrophic lateral sclerosis	0.00607	0.00905	CbGpPWpGaD
Tubocurarine—ACHE—Glycerophospholipid biosynthesis—PLB1—amyotrophic lateral sclerosis	0.00597	0.0089	CbGpPWpGaD
Tubocurarine—CHRM2—nervous system—amyotrophic lateral sclerosis	0.00593	0.018	CbGeAlD
Tubocurarine—SLC22A1—nervous system—amyotrophic lateral sclerosis	0.00583	0.0177	CbGeAlD
Tubocurarine—SLC22A2—Neurotransmitter Release Cycle—SLC6A1—amyotrophic lateral sclerosis	0.00581	0.00866	CbGpPWpGaD
Tubocurarine—CHRND—Transmission across Chemical Synapses—GRIA2—amyotrophic lateral sclerosis	0.00572	0.00852	CbGpPWpGaD
Tubocurarine—CHRM2—central nervous system—amyotrophic lateral sclerosis	0.00571	0.0174	CbGeAlD
Tubocurarine—CHRNA1—Neurotransmitter Receptor Binding And Downstream Transmission In The Postsynaptic Cell—NEFL—amyotrophic lateral sclerosis	0.00571	0.00852	CbGpPWpGaD
Tubocurarine—ACHE—Synthesis, secretion, and deacylation of Ghrelin—IGF1—amyotrophic lateral sclerosis	0.00566	0.00844	CbGpPWpGaD
Tubocurarine—SLC22A1—central nervous system—amyotrophic lateral sclerosis	0.00561	0.0171	CbGeAlD
Tubocurarine—CHRND—Transmission across Chemical Synapses—SLC1A2—amyotrophic lateral sclerosis	0.00552	0.00823	CbGpPWpGaD
Tubocurarine—HTR3A—brain—amyotrophic lateral sclerosis	0.00544	0.0165	CbGeAlD
Tubocurarine—CHRNA2—Neurotransmitter Receptor Binding And Downstream Transmission In The Postsynaptic Cell—NEFL—amyotrophic lateral sclerosis	0.00543	0.00809	CbGpPWpGaD
Tubocurarine—SLC22A1—Neurotransmitter Release Cycle—SLC6A1—amyotrophic lateral sclerosis	0.00541	0.00807	CbGpPWpGaD
Tubocurarine—HTR3A—SIDS Susceptibility Pathways—SLC1A3—amyotrophic lateral sclerosis	0.00527	0.00786	CbGpPWpGaD
Tubocurarine—HTR3A—SIDS Susceptibility Pathways—CHAT—amyotrophic lateral sclerosis	0.00527	0.00786	CbGpPWpGaD
Tubocurarine—HTR3A—SIDS Susceptibility Pathways—AQP4—amyotrophic lateral sclerosis	0.00527	0.00786	CbGpPWpGaD
Tubocurarine—CHRNA1—Transmission across Chemical Synapses—KCNJ10—amyotrophic lateral sclerosis	0.00527	0.00785	CbGpPWpGaD
Tubocurarine—CHRND—Transmission across Chemical Synapses—NEFL—amyotrophic lateral sclerosis	0.00505	0.00753	CbGpPWpGaD
Tubocurarine—CHRNA2—Transmission across Chemical Synapses—KCNJ10—amyotrophic lateral sclerosis	0.00501	0.00746	CbGpPWpGaD
Tubocurarine—CHRNA1—Transmission across Chemical Synapses—GRIA2—amyotrophic lateral sclerosis	0.00486	0.00725	CbGpPWpGaD
Tubocurarine—CHRND—Neuronal System—KCNJ10—amyotrophic lateral sclerosis	0.00475	0.00708	CbGpPWpGaD
Tubocurarine—CHRNA1—Transmission across Chemical Synapses—SLC1A2—amyotrophic lateral sclerosis	0.0047	0.007	CbGpPWpGaD
Tubocurarine—CHRND—Transmission across Chemical Synapses—SLC1A3—amyotrophic lateral sclerosis	0.0047	0.007	CbGpPWpGaD
Tubocurarine—CHRND—Transmission across Chemical Synapses—CHAT—amyotrophic lateral sclerosis	0.0047	0.007	CbGpPWpGaD
Tubocurarine—CHRNA2—Transmission across Chemical Synapses—GRIA2—amyotrophic lateral sclerosis	0.00462	0.00689	CbGpPWpGaD
Tubocurarine—CHRM2—brain—amyotrophic lateral sclerosis	0.00454	0.0138	CbGeAlD
Tubocurarine—ACHE—Glycerophospholipid biosynthesis—CHAT—amyotrophic lateral sclerosis	0.00453	0.00674	CbGpPWpGaD
Tubocurarine—ACHE—Melatonin metabolism and effects—APOE—amyotrophic lateral sclerosis	0.00447	0.00666	CbGpPWpGaD
Tubocurarine—CHRNA2—Transmission across Chemical Synapses—SLC1A2—amyotrophic lateral sclerosis	0.00446	0.00665	CbGpPWpGaD
Tubocurarine—SLC22A1—brain—amyotrophic lateral sclerosis	0.00446	0.0135	CbGeAlD
Tubocurarine—CHRND—Neuronal System—GRIA2—amyotrophic lateral sclerosis	0.00438	0.00653	CbGpPWpGaD
Tubocurarine—CHRNA1—Transmission across Chemical Synapses—NEFL—amyotrophic lateral sclerosis	0.00429	0.0064	CbGpPWpGaD
Tubocurarine—CHRND—Neuronal System—SLC1A2—amyotrophic lateral sclerosis	0.00423	0.00631	CbGpPWpGaD
Tubocurarine—CHRND—Transmission across Chemical Synapses—SLC6A1—amyotrophic lateral sclerosis	0.00419	0.00624	CbGpPWpGaD
Tubocurarine—ACHE—Phospholipid metabolism—PLB1—amyotrophic lateral sclerosis	0.00417	0.00621	CbGpPWpGaD
Tubocurarine—CHRNA2—Transmission across Chemical Synapses—NEFL—amyotrophic lateral sclerosis	0.00408	0.00608	CbGpPWpGaD
Tubocurarine—CHRNA1—Neuronal System—KCNJ10—amyotrophic lateral sclerosis	0.00404	0.00602	CbGpPWpGaD
Tubocurarine—CHRNA1—Transmission across Chemical Synapses—SLC1A3—amyotrophic lateral sclerosis	0.00399	0.00595	CbGpPWpGaD
Tubocurarine—CHRNA1—Transmission across Chemical Synapses—CHAT—amyotrophic lateral sclerosis	0.00399	0.00595	CbGpPWpGaD
Tubocurarine—CHRND—Neuronal System—NEFL—amyotrophic lateral sclerosis	0.00387	0.00577	CbGpPWpGaD
Tubocurarine—CHRNA2—Neuronal System—KCNJ10—amyotrophic lateral sclerosis	0.00384	0.00572	CbGpPWpGaD
Tubocurarine—CHRNA2—Transmission across Chemical Synapses—CHAT—amyotrophic lateral sclerosis	0.00379	0.00565	CbGpPWpGaD
Tubocurarine—CHRNA2—Transmission across Chemical Synapses—SLC1A3—amyotrophic lateral sclerosis	0.00379	0.00565	CbGpPWpGaD
Tubocurarine—ACHE—Integrated Pancreatic Cancer Pathway—CASP12—amyotrophic lateral sclerosis	0.00378	0.00563	CbGpPWpGaD
Tubocurarine—CHRNA1—Neuronal System—GRIA2—amyotrophic lateral sclerosis	0.00373	0.00555	CbGpPWpGaD
Tubocurarine—CHRND—Neuronal System—SLC1A3—amyotrophic lateral sclerosis	0.0036	0.00536	CbGpPWpGaD
Tubocurarine—CHRNA1—Neuronal System—SLC1A2—amyotrophic lateral sclerosis	0.0036	0.00536	CbGpPWpGaD
Tubocurarine—CHRND—Neuronal System—CHAT—amyotrophic lateral sclerosis	0.0036	0.00536	CbGpPWpGaD
Tubocurarine—CHRNA1—Transmission across Chemical Synapses—SLC6A1—amyotrophic lateral sclerosis	0.00356	0.0053	CbGpPWpGaD
Tubocurarine—CHRNA2—Neuronal System—GRIA2—amyotrophic lateral sclerosis	0.00354	0.00528	CbGpPWpGaD
Tubocurarine—CHRNA2—Neuronal System—SLC1A2—amyotrophic lateral sclerosis	0.00342	0.00509	CbGpPWpGaD
Tubocurarine—CHRNA2—Transmission across Chemical Synapses—SLC6A1—amyotrophic lateral sclerosis	0.00338	0.00504	CbGpPWpGaD
Tubocurarine—CHRNA1—Neuronal System—NEFL—amyotrophic lateral sclerosis	0.00329	0.0049	CbGpPWpGaD
Tubocurarine—HTR3A—Transmembrane transport of small molecules—TRPM7—amyotrophic lateral sclerosis	0.00325	0.00484	CbGpPWpGaD
Tubocurarine—CHRND—Neuronal System—SLC6A1—amyotrophic lateral sclerosis	0.00321	0.00478	CbGpPWpGaD
Tubocurarine—ACHE—Phospholipid metabolism—CHAT—amyotrophic lateral sclerosis	0.00316	0.00471	CbGpPWpGaD
Tubocurarine—CHRNA2—Neuronal System—NEFL—amyotrophic lateral sclerosis	0.00313	0.00466	CbGpPWpGaD
Tubocurarine—ACHE—Transmission across Chemical Synapses—KCNJ10—amyotrophic lateral sclerosis	0.0031	0.00461	CbGpPWpGaD
Tubocurarine—ACHE—Integrated Pancreatic Cancer Pathway—RARA—amyotrophic lateral sclerosis	0.00308	0.00459	CbGpPWpGaD
Tubocurarine—CHRNA1—Neuronal System—CHAT—amyotrophic lateral sclerosis	0.00306	0.00456	CbGpPWpGaD
Tubocurarine—CHRNA1—Neuronal System—SLC1A3—amyotrophic lateral sclerosis	0.00306	0.00456	CbGpPWpGaD
Tubocurarine—CHRM2—SIDS Susceptibility Pathways—ECE1—amyotrophic lateral sclerosis	0.00302	0.0045	CbGpPWpGaD
Tubocurarine—SLC22A2—Transport of glucose and other sugars, bile salts and organic acids, metal ions and amine compounds—SLC6A1—amyotrophic lateral sclerosis	0.00297	0.00443	CbGpPWpGaD
Tubocurarine—CHRNA2—Neuronal System—SLC1A3—amyotrophic lateral sclerosis	0.00291	0.00433	CbGpPWpGaD
Tubocurarine—CHRNA2—Neuronal System—CHAT—amyotrophic lateral sclerosis	0.00291	0.00433	CbGpPWpGaD
Tubocurarine—ACHE—Transmission across Chemical Synapses—GRIA2—amyotrophic lateral sclerosis	0.00286	0.00426	CbGpPWpGaD
Tubocurarine—ACHE—Metabolism of proteins—IGFALS—amyotrophic lateral sclerosis	0.00279	0.00416	CbGpPWpGaD
Tubocurarine—SLC22A1—Transport of glucose and other sugars, bile salts and organic acids, metal ions and amine compounds—SLC6A1—amyotrophic lateral sclerosis	0.00277	0.00413	CbGpPWpGaD
Tubocurarine—ACHE—Transmission across Chemical Synapses—SLC1A2—amyotrophic lateral sclerosis	0.00276	0.00411	CbGpPWpGaD
Tubocurarine—HTR3A—SIDS Susceptibility Pathways—BDNF—amyotrophic lateral sclerosis	0.00273	0.00407	CbGpPWpGaD
Tubocurarine—CHRNA1—Neuronal System—SLC6A1—amyotrophic lateral sclerosis	0.00273	0.00406	CbGpPWpGaD
Tubocurarine—CHRNA2—Neuronal System—SLC6A1—amyotrophic lateral sclerosis	0.00259	0.00386	CbGpPWpGaD
Tubocurarine—ACHE—Transmission across Chemical Synapses—NEFL—amyotrophic lateral sclerosis	0.00252	0.00376	CbGpPWpGaD
Tubocurarine—SLC22A2—Transmission across Chemical Synapses—KCNJ10—amyotrophic lateral sclerosis	0.00247	0.00368	CbGpPWpGaD
Tubocurarine—ACHE—Metabolism of lipids and lipoproteins—VAPB—amyotrophic lateral sclerosis	0.00245	0.00365	CbGpPWpGaD
Tubocurarine—ACHE—Neuronal System—KCNJ10—amyotrophic lateral sclerosis	0.00237	0.00354	CbGpPWpGaD
Tubocurarine—ACHE—Transmission across Chemical Synapses—CHAT—amyotrophic lateral sclerosis	0.00235	0.0035	CbGpPWpGaD
Tubocurarine—ACHE—Transmission across Chemical Synapses—SLC1A3—amyotrophic lateral sclerosis	0.00235	0.0035	CbGpPWpGaD
Tubocurarine—SLC22A1—Transmission across Chemical Synapses—KCNJ10—amyotrophic lateral sclerosis	0.0023	0.00343	CbGpPWpGaD
Tubocurarine—CHRM2—Regulation of Actin Cytoskeleton—PFN1—amyotrophic lateral sclerosis	0.0023	0.00342	CbGpPWpGaD
Tubocurarine—SLC22A2—Transmission across Chemical Synapses—GRIA2—amyotrophic lateral sclerosis	0.00228	0.00339	CbGpPWpGaD
Tubocurarine—ACHE—Metabolism of lipids and lipoproteins—VAPA—amyotrophic lateral sclerosis	0.00224	0.00334	CbGpPWpGaD
Tubocurarine—ACHE—Glycerophospholipid biosynthesis—PLA2G4A—amyotrophic lateral sclerosis	0.00223	0.00333	CbGpPWpGaD
Tubocurarine—SLC22A2—Transmission across Chemical Synapses—SLC1A2—amyotrophic lateral sclerosis	0.0022	0.00328	CbGpPWpGaD
Tubocurarine—ACHE—Neuronal System—GRIA2—amyotrophic lateral sclerosis	0.00219	0.00326	CbGpPWpGaD
Tubocurarine—SLC22A1—Transmission across Chemical Synapses—GRIA2—amyotrophic lateral sclerosis	0.00212	0.00316	CbGpPWpGaD
Tubocurarine—ACHE—Integrated Pancreatic Cancer Pathway—MAPT—amyotrophic lateral sclerosis	0.00212	0.00316	CbGpPWpGaD
Tubocurarine—ACHE—Metabolism of proteins—PIGW—amyotrophic lateral sclerosis	0.00212	0.00315	CbGpPWpGaD
Tubocurarine—ACHE—Neuronal System—SLC1A2—amyotrophic lateral sclerosis	0.00211	0.00315	CbGpPWpGaD
Tubocurarine—HTR3A—Transmembrane transport of small molecules—SLC1A2—amyotrophic lateral sclerosis	0.00209	0.00312	CbGpPWpGaD
Tubocurarine—ACHE—Transmission across Chemical Synapses—SLC6A1—amyotrophic lateral sclerosis	0.00209	0.00312	CbGpPWpGaD
Tubocurarine—ACHE—Metabolism of lipids and lipoproteins—SACM1L—amyotrophic lateral sclerosis	0.00208	0.0031	CbGpPWpGaD
Tubocurarine—ACHE—Integrated Pancreatic Cancer Pathway—CST3—amyotrophic lateral sclerosis	0.00205	0.00306	CbGpPWpGaD
Tubocurarine—SLC22A1—Transmission across Chemical Synapses—SLC1A2—amyotrophic lateral sclerosis	0.00205	0.00305	CbGpPWpGaD
Tubocurarine—SLC22A2—Transmission across Chemical Synapses—NEFL—amyotrophic lateral sclerosis	0.00201	0.003	CbGpPWpGaD
Tubocurarine—ACHE—Metabolism of lipids and lipoproteins—FIG4—amyotrophic lateral sclerosis	0.00196	0.00292	CbGpPWpGaD
Tubocurarine—CHRM2—SIDS Susceptibility Pathways—SLC1A3—amyotrophic lateral sclerosis	0.00194	0.0029	CbGpPWpGaD
Tubocurarine—CHRM2—SIDS Susceptibility Pathways—CHAT—amyotrophic lateral sclerosis	0.00194	0.0029	CbGpPWpGaD
Tubocurarine—CHRM2—SIDS Susceptibility Pathways—AQP4—amyotrophic lateral sclerosis	0.00194	0.0029	CbGpPWpGaD
Tubocurarine—ACHE—Metabolism of proteins—XRN2—amyotrophic lateral sclerosis	0.00193	0.00288	CbGpPWpGaD
Tubocurarine—ACHE—Integrated Pancreatic Cancer Pathway—IGFBP3—amyotrophic lateral sclerosis	0.00193	0.00288	CbGpPWpGaD
Tubocurarine—ACHE—Neuronal System—NEFL—amyotrophic lateral sclerosis	0.00193	0.00288	CbGpPWpGaD
Tubocurarine—SLC22A2—Neuronal System—KCNJ10—amyotrophic lateral sclerosis	0.00189	0.00282	CbGpPWpGaD
Tubocurarine—SLC22A1—Transmission across Chemical Synapses—NEFL—amyotrophic lateral sclerosis	0.00187	0.00279	CbGpPWpGaD
Tubocurarine—SLC22A2—Transmission across Chemical Synapses—CHAT—amyotrophic lateral sclerosis	0.00187	0.00279	CbGpPWpGaD
Tubocurarine—SLC22A2—Transmission across Chemical Synapses—SLC1A3—amyotrophic lateral sclerosis	0.00187	0.00279	CbGpPWpGaD
Tubocurarine—ACHE—Neuronal System—SLC1A3—amyotrophic lateral sclerosis	0.0018	0.00268	CbGpPWpGaD
Tubocurarine—ACHE—Neuronal System—CHAT—amyotrophic lateral sclerosis	0.0018	0.00268	CbGpPWpGaD
Tubocurarine—SLC22A2—SLC-mediated transmembrane transport—SLC1A2—amyotrophic lateral sclerosis	0.00178	0.00266	CbGpPWpGaD
Tubocurarine—HTR3A—Transmembrane transport of small molecules—AQP4—amyotrophic lateral sclerosis	0.00178	0.00265	CbGpPWpGaD
Tubocurarine—HTR3A—Transmembrane transport of small molecules—SLC1A3—amyotrophic lateral sclerosis	0.00178	0.00265	CbGpPWpGaD
Tubocurarine—SLC22A1—Neuronal System—KCNJ10—amyotrophic lateral sclerosis	0.00176	0.00263	CbGpPWpGaD
Tubocurarine—SLC22A2—Neuronal System—GRIA2—amyotrophic lateral sclerosis	0.00174	0.0026	CbGpPWpGaD
Tubocurarine—SLC22A1—Transmission across Chemical Synapses—CHAT—amyotrophic lateral sclerosis	0.00174	0.0026	CbGpPWpGaD
Tubocurarine—SLC22A1—Transmission across Chemical Synapses—SLC1A3—amyotrophic lateral sclerosis	0.00174	0.0026	CbGpPWpGaD
Tubocurarine—SLC22A2—Neuronal System—SLC1A2—amyotrophic lateral sclerosis	0.00168	0.00251	CbGpPWpGaD
Tubocurarine—SLC22A2—Transmission across Chemical Synapses—SLC6A1—amyotrophic lateral sclerosis	0.00167	0.00248	CbGpPWpGaD
Tubocurarine—SLC22A1—SLC-mediated transmembrane transport—SLC1A2—amyotrophic lateral sclerosis	0.00166	0.00248	CbGpPWpGaD
Tubocurarine—SLC22A1—Neuronal System—GRIA2—amyotrophic lateral sclerosis	0.00163	0.00242	CbGpPWpGaD
Tubocurarine—ACHE—Metabolism of proteins—YIF1A—amyotrophic lateral sclerosis	0.0016	0.00239	CbGpPWpGaD
Tubocurarine—ACHE—Neuronal System—SLC6A1—amyotrophic lateral sclerosis	0.0016	0.00239	CbGpPWpGaD
Tubocurarine—HTR3A—Transmembrane transport of small molecules—SLC6A1—amyotrophic lateral sclerosis	0.00159	0.00237	CbGpPWpGaD
Tubocurarine—SLC22A1—Neuronal System—SLC1A2—amyotrophic lateral sclerosis	0.00157	0.00234	CbGpPWpGaD
Tubocurarine—ACHE—Peptide hormone metabolism—IGF1—amyotrophic lateral sclerosis	0.00156	0.00233	CbGpPWpGaD
Tubocurarine—ACHE—Phospholipid metabolism—PLA2G4A—amyotrophic lateral sclerosis	0.00156	0.00232	CbGpPWpGaD
Tubocurarine—SLC22A1—Transmission across Chemical Synapses—SLC6A1—amyotrophic lateral sclerosis	0.00155	0.00231	CbGpPWpGaD
Tubocurarine—SLC22A2—Neuronal System—NEFL—amyotrophic lateral sclerosis	0.00154	0.0023	CbGpPWpGaD
Tubocurarine—SLC22A2—SLC-mediated transmembrane transport—SLC1A3—amyotrophic lateral sclerosis	0.00152	0.00226	CbGpPWpGaD
Tubocurarine—ACHE—Integrated Pancreatic Cancer Pathway—CASP9—amyotrophic lateral sclerosis	0.00149	0.00223	CbGpPWpGaD
Tubocurarine—SLC22A1—Neuronal System—NEFL—amyotrophic lateral sclerosis	0.00144	0.00214	CbGpPWpGaD
Tubocurarine—SLC22A2—Neuronal System—SLC1A3—amyotrophic lateral sclerosis	0.00143	0.00214	CbGpPWpGaD
Tubocurarine—SLC22A2—Neuronal System—CHAT—amyotrophic lateral sclerosis	0.00143	0.00214	CbGpPWpGaD
Tubocurarine—SLC22A1—SLC-mediated transmembrane transport—SLC1A3—amyotrophic lateral sclerosis	0.00141	0.00211	CbGpPWpGaD
Tubocurarine—SLC22A2—Transmembrane transport of small molecules—TRPM7—amyotrophic lateral sclerosis	0.00141	0.0021	CbGpPWpGaD
Tubocurarine—CHRM2—G alpha (i) signalling events—C5AR1—amyotrophic lateral sclerosis	0.0014	0.00209	CbGpPWpGaD
Tubocurarine—HTR3A—SIDS Susceptibility Pathways—CASP3—amyotrophic lateral sclerosis	0.00136	0.00203	CbGpPWpGaD
Tubocurarine—SLC22A2—SLC-mediated transmembrane transport—SLC6A1—amyotrophic lateral sclerosis	0.00135	0.00201	CbGpPWpGaD
Tubocurarine—ACHE—Metabolism of lipids and lipoproteins—PLB1—amyotrophic lateral sclerosis	0.00134	0.002	CbGpPWpGaD
Tubocurarine—SLC22A1—Neuronal System—CHAT—amyotrophic lateral sclerosis	0.00134	0.00199	CbGpPWpGaD
Tubocurarine—SLC22A1—Neuronal System—SLC1A3—amyotrophic lateral sclerosis	0.00134	0.00199	CbGpPWpGaD
Tubocurarine—ACHE—Metabolism of proteins—EXOSC9—amyotrophic lateral sclerosis	0.00132	0.00197	CbGpPWpGaD
Tubocurarine—SLC22A1—Transmembrane transport of small molecules—TRPM7—amyotrophic lateral sclerosis	0.00131	0.00195	CbGpPWpGaD
Tubocurarine—SLC22A2—Neuronal System—SLC6A1—amyotrophic lateral sclerosis	0.00128	0.0019	CbGpPWpGaD
Tubocurarine—ACHE—Integrated Pancreatic Cancer Pathway—BDNF—amyotrophic lateral sclerosis	0.00126	0.00188	CbGpPWpGaD
Tubocurarine—SLC22A1—SLC-mediated transmembrane transport—SLC6A1—amyotrophic lateral sclerosis	0.00126	0.00188	CbGpPWpGaD
Tubocurarine—ACHE—Integrated Pancreatic Cancer Pathway—PLA2G4A—amyotrophic lateral sclerosis	0.0012	0.00179	CbGpPWpGaD
Tubocurarine—SLC22A1—Neuronal System—SLC6A1—amyotrophic lateral sclerosis	0.00119	0.00177	CbGpPWpGaD
Tubocurarine—HTR3A—SIDS Susceptibility Pathways—VEGFA—amyotrophic lateral sclerosis	0.00116	0.00172	CbGpPWpGaD
Tubocurarine—CHRM2—Class A/1 (Rhodopsin-like receptors)—C5AR1—amyotrophic lateral sclerosis	0.00111	0.00166	CbGpPWpGaD
Tubocurarine—ACHE—Metabolism of proteins—TUBA4A—amyotrophic lateral sclerosis	0.00111	0.00166	CbGpPWpGaD
Tubocurarine—ACHE—Metabolism—TPK1—amyotrophic lateral sclerosis	0.00109	0.00163	CbGpPWpGaD
Tubocurarine—ACHE—Metabolism—VAPB—amyotrophic lateral sclerosis	0.00109	0.00163	CbGpPWpGaD
Tubocurarine—ACHE—Metabolism of lipids and lipoproteins—CHAT—amyotrophic lateral sclerosis	0.00102	0.00152	CbGpPWpGaD
Tubocurarine—CHRM2—SIDS Susceptibility Pathways—BDNF—amyotrophic lateral sclerosis	0.00101	0.0015	CbGpPWpGaD
Tubocurarine—ACHE—Metabolism—VAPA—amyotrophic lateral sclerosis	0.000997	0.00149	CbGpPWpGaD
Tubocurarine—ACHE—Metabolism of proteins—DCTN1—amyotrophic lateral sclerosis	0.000945	0.00141	CbGpPWpGaD
Tubocurarine—ACHE—Metabolism—SACM1L—amyotrophic lateral sclerosis	0.000927	0.00138	CbGpPWpGaD
Tubocurarine—SLC22A2—Transmembrane transport of small molecules—SLC1A2—amyotrophic lateral sclerosis	0.000906	0.00135	CbGpPWpGaD
Tubocurarine—ACHE—Metabolism—FIG4—amyotrophic lateral sclerosis	0.000872	0.0013	CbGpPWpGaD
Tubocurarine—SLC22A2—Metabolism—TPK1—amyotrophic lateral sclerosis	0.000869	0.00129	CbGpPWpGaD
Tubocurarine—SLC22A2—Metabolism—VAPB—amyotrophic lateral sclerosis	0.000869	0.00129	CbGpPWpGaD
Tubocurarine—CHRM2—GPCR ligand binding—C5AR1—amyotrophic lateral sclerosis	0.000848	0.00126	CbGpPWpGaD
Tubocurarine—SLC22A1—Transmembrane transport of small molecules—SLC1A2—amyotrophic lateral sclerosis	0.000844	0.00126	CbGpPWpGaD
Tubocurarine—ACHE—Integrated Pancreatic Cancer Pathway—IGF1—amyotrophic lateral sclerosis	0.000817	0.00122	CbGpPWpGaD
Tubocurarine—SLC22A1—Metabolism—TPK1—amyotrophic lateral sclerosis	0.00081	0.00121	CbGpPWpGaD
Tubocurarine—SLC22A1—Metabolism—VAPB—amyotrophic lateral sclerosis	0.00081	0.00121	CbGpPWpGaD
Tubocurarine—SLC22A2—Metabolism—VAPA—amyotrophic lateral sclerosis	0.000794	0.00118	CbGpPWpGaD
Tubocurarine—ACHE—Metabolism—DAO—amyotrophic lateral sclerosis	0.000788	0.00117	CbGpPWpGaD
Tubocurarine—SLC22A2—Transmembrane transport of small molecules—AQP4—amyotrophic lateral sclerosis	0.00077	0.00115	CbGpPWpGaD
Tubocurarine—SLC22A2—Transmembrane transport of small molecules—SLC1A3—amyotrophic lateral sclerosis	0.00077	0.00115	CbGpPWpGaD
Tubocurarine—SLC22A1—Metabolism—VAPA—amyotrophic lateral sclerosis	0.000741	0.0011	CbGpPWpGaD
Tubocurarine—SLC22A2—Metabolism—SACM1L—amyotrophic lateral sclerosis	0.000739	0.0011	CbGpPWpGaD
Tubocurarine—SLC22A1—Transmembrane transport of small molecules—SLC1A3—amyotrophic lateral sclerosis	0.000718	0.00107	CbGpPWpGaD
Tubocurarine—SLC22A1—Transmembrane transport of small molecules—AQP4—amyotrophic lateral sclerosis	0.000718	0.00107	CbGpPWpGaD
Tubocurarine—ACHE—Metabolism of proteins—IGFBP3—amyotrophic lateral sclerosis	0.000698	0.00104	CbGpPWpGaD
Tubocurarine—SLC22A2—Metabolism—FIG4—amyotrophic lateral sclerosis	0.000694	0.00104	CbGpPWpGaD
Tubocurarine—SLC22A1—Metabolism—SACM1L—amyotrophic lateral sclerosis	0.000688	0.00103	CbGpPWpGaD
Tubocurarine—SLC22A2—Transmembrane transport of small molecules—SLC6A1—amyotrophic lateral sclerosis	0.000686	0.00102	CbGpPWpGaD
Tubocurarine—ACHE—Integrated Pancreatic Cancer Pathway—PTGS2—amyotrophic lateral sclerosis	0.000678	0.00101	CbGpPWpGaD
Tubocurarine—SLC22A1—Metabolism—FIG4—amyotrophic lateral sclerosis	0.000647	0.000965	CbGpPWpGaD
Tubocurarine—SLC22A1—Transmembrane transport of small molecules—SLC6A1—amyotrophic lateral sclerosis	0.00064	0.000954	CbGpPWpGaD
Tubocurarine—ACHE—Integrated Pancreatic Cancer Pathway—CASP3—amyotrophic lateral sclerosis	0.000629	0.000938	CbGpPWpGaD
Tubocurarine—SLC22A2—Metabolism—DAO—amyotrophic lateral sclerosis	0.000628	0.000936	CbGpPWpGaD
Tubocurarine—CHRM2—G alpha (i) signalling events—C3—amyotrophic lateral sclerosis	0.000612	0.000912	CbGpPWpGaD
Tubocurarine—ACHE—Metabolism—PLB1—amyotrophic lateral sclerosis	0.000597	0.00089	CbGpPWpGaD
Tubocurarine—SLC22A1—Metabolism—DAO—amyotrophic lateral sclerosis	0.000585	0.000872	CbGpPWpGaD
Tubocurarine—ACHE—Metabolism—GSR—amyotrophic lateral sclerosis	0.000551	0.000822	CbGpPWpGaD
Tubocurarine—ACHE—Integrated Pancreatic Cancer Pathway—VEGFA—amyotrophic lateral sclerosis	0.000534	0.000796	CbGpPWpGaD
Tubocurarine—CHRM2—SIDS Susceptibility Pathways—CASP3—amyotrophic lateral sclerosis	0.000503	0.000749	CbGpPWpGaD
Tubocurarine—ACHE—Metabolism of lipids and lipoproteins—PLA2G4A—amyotrophic lateral sclerosis	0.000502	0.000748	CbGpPWpGaD
Tubocurarine—CHRM2—Class A/1 (Rhodopsin-like receptors)—C3—amyotrophic lateral sclerosis	0.000486	0.000725	CbGpPWpGaD
Tubocurarine—CHRM2—GPCR downstream signaling—C5AR1—amyotrophic lateral sclerosis	0.000479	0.000715	CbGpPWpGaD
Tubocurarine—SLC22A2—Metabolism—PLB1—amyotrophic lateral sclerosis	0.000476	0.000709	CbGpPWpGaD
Tubocurarine—ACHE—Metabolism—CHAT—amyotrophic lateral sclerosis	0.000453	0.000675	CbGpPWpGaD
Tubocurarine—SLC22A1—Metabolism—PLB1—amyotrophic lateral sclerosis	0.000444	0.000661	CbGpPWpGaD
Tubocurarine—SLC22A2—Metabolism—GSR—amyotrophic lateral sclerosis	0.000439	0.000655	CbGpPWpGaD
Tubocurarine—CHRM2—Signaling by GPCR—C5AR1—amyotrophic lateral sclerosis	0.000435	0.000649	CbGpPWpGaD
Tubocurarine—CHRM2—SIDS Susceptibility Pathways—VEGFA—amyotrophic lateral sclerosis	0.000426	0.000636	CbGpPWpGaD
Tubocurarine—ACHE—Metabolism of lipids and lipoproteins—APOE—amyotrophic lateral sclerosis	0.000413	0.000616	CbGpPWpGaD
Tubocurarine—SLC22A1—Metabolism—GSR—amyotrophic lateral sclerosis	0.000409	0.00061	CbGpPWpGaD
Tubocurarine—ACHE—Integrated Pancreatic Cancer Pathway—TP53—amyotrophic lateral sclerosis	0.000403	0.000601	CbGpPWpGaD
Tubocurarine—CHRM2—GPCR ligand binding—C3—amyotrophic lateral sclerosis	0.00037	0.000552	CbGpPWpGaD
Tubocurarine—SLC22A2—Metabolism—CHAT—amyotrophic lateral sclerosis	0.000361	0.000538	CbGpPWpGaD
Tubocurarine—CHRM2—Signaling Pathways—PLB1—amyotrophic lateral sclerosis	0.000339	0.000506	CbGpPWpGaD
Tubocurarine—SLC22A1—Metabolism—CHAT—amyotrophic lateral sclerosis	0.000336	0.000501	CbGpPWpGaD
Tubocurarine—CHRM2—Signaling Pathways—RTN4—amyotrophic lateral sclerosis	0.000319	0.000476	CbGpPWpGaD
Tubocurarine—CHRM2—Signaling Pathways—VCP—amyotrophic lateral sclerosis	0.000302	0.000451	CbGpPWpGaD
Tubocurarine—ACHE—Metabolism of proteins—IGF1—amyotrophic lateral sclerosis	0.000295	0.00044	CbGpPWpGaD
Tubocurarine—CHRM2—Signaling Pathways—PFN1—amyotrophic lateral sclerosis	0.000293	0.000437	CbGpPWpGaD
Tubocurarine—ACHE—Metabolism of lipids and lipoproteins—PTGS2—amyotrophic lateral sclerosis	0.000283	0.000422	CbGpPWpGaD
Tubocurarine—CHRM2—Signaling Pathways—GFAP—amyotrophic lateral sclerosis	0.00026	0.000388	CbGpPWpGaD
Tubocurarine—CHRM2—Signaling Pathways—C5AR1—amyotrophic lateral sclerosis	0.000257	0.000383	CbGpPWpGaD
Tubocurarine—ACHE—Metabolism—GSTP1—amyotrophic lateral sclerosis	0.000243	0.000363	CbGpPWpGaD
Tubocurarine—ACHE—Metabolism—PLA2G4A—amyotrophic lateral sclerosis	0.000224	0.000333	CbGpPWpGaD
Tubocurarine—CHRM2—Signaling by GPCR—PLA2G4A—amyotrophic lateral sclerosis	0.000215	0.00032	CbGpPWpGaD
Tubocurarine—CHRM2—GPCR downstream signaling—C3—amyotrophic lateral sclerosis	0.000209	0.000312	CbGpPWpGaD
Tubocurarine—SLC22A2—Metabolism—GSTP1—amyotrophic lateral sclerosis	0.000194	0.000289	CbGpPWpGaD
Tubocurarine—CHRM2—Signaling by GPCR—C3—amyotrophic lateral sclerosis	0.00019	0.000283	CbGpPWpGaD
Tubocurarine—ACHE—Metabolism—APOE—amyotrophic lateral sclerosis	0.000184	0.000274	CbGpPWpGaD
Tubocurarine—SLC22A1—Metabolism—GSTP1—amyotrophic lateral sclerosis	0.000181	0.000269	CbGpPWpGaD
Tubocurarine—SLC22A2—Metabolism—PLA2G4A—amyotrophic lateral sclerosis	0.000178	0.000266	CbGpPWpGaD
Tubocurarine—CHRM2—Signaling Pathways—SQSTM1—amyotrophic lateral sclerosis	0.000177	0.000263	CbGpPWpGaD
Tubocurarine—SLC22A1—Metabolism—PLA2G4A—amyotrophic lateral sclerosis	0.000166	0.000247	CbGpPWpGaD
Tubocurarine—CHRM2—Signaling Pathways—ATF1—amyotrophic lateral sclerosis	0.000166	0.000247	CbGpPWpGaD
Tubocurarine—CHRM2—Signaling Pathways—CASP9—amyotrophic lateral sclerosis	0.000158	0.000235	CbGpPWpGaD
Tubocurarine—SLC22A2—Metabolism—APOE—amyotrophic lateral sclerosis	0.000147	0.000218	CbGpPWpGaD
Tubocurarine—SLC22A1—Metabolism—APOE—amyotrophic lateral sclerosis	0.000137	0.000204	CbGpPWpGaD
Tubocurarine—CHRM2—Signaling Pathways—ERBB4—amyotrophic lateral sclerosis	0.000135	0.000201	CbGpPWpGaD
Tubocurarine—CHRM2—Signaling Pathways—PLA2G4A—amyotrophic lateral sclerosis	0.000127	0.000189	CbGpPWpGaD
Tubocurarine—ACHE—Metabolism—PTGS2—amyotrophic lateral sclerosis	0.000126	0.000188	CbGpPWpGaD
Tubocurarine—CHRM2—Signaling Pathways—C3—amyotrophic lateral sclerosis	0.000112	0.000167	CbGpPWpGaD
Tubocurarine—CHRM2—Signaling Pathways—APOE—amyotrophic lateral sclerosis	0.000104	0.000156	CbGpPWpGaD
Tubocurarine—SLC22A2—Metabolism—PTGS2—amyotrophic lateral sclerosis	0.0001	0.00015	CbGpPWpGaD
Tubocurarine—SLC22A1—Metabolism—PTGS2—amyotrophic lateral sclerosis	9.36e-05	0.00014	CbGpPWpGaD
Tubocurarine—CHRM2—Signaling Pathways—IGF1—amyotrophic lateral sclerosis	8.63e-05	0.000129	CbGpPWpGaD
Tubocurarine—CHRM2—Signaling Pathways—CASP3—amyotrophic lateral sclerosis	6.65e-05	9.91e-05	CbGpPWpGaD
Tubocurarine—CHRM2—Signaling Pathways—MMP9—amyotrophic lateral sclerosis	6.28e-05	9.36e-05	CbGpPWpGaD
Tubocurarine—CHRM2—Signaling Pathways—VEGFA—amyotrophic lateral sclerosis	5.64e-05	8.41e-05	CbGpPWpGaD
Tubocurarine—CHRM2—Signaling Pathways—TP53—amyotrophic lateral sclerosis	4.26e-05	6.35e-05	CbGpPWpGaD
